Bedell Frazier Investment Counselling’s Idexx Laboratories IDXX Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$250K	–	90
2023 Q1	$250K	Hold	500	–	–	0.07%	86
2022 Q4	$204K	Buy	+500	New	+$194K	0.05%	101
2022 Q2	–	Sell	-500	Closed	-$274K	–	88
2022 Q1	$274K	Hold	500	–	–	0.07%	79
2021 Q4	$329K	Hold	500	–	–	0.08%	86
2021 Q3	$311K	Hold	500	–	–	0.09%	80
2021 Q2	$316K	Hold	500	–	–	0.08%	79
2021 Q1	$245K	Buy	+500	New	+$251K	0.07%	80

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Bedell Frazier Investment Counselling's IDXX Position: Q2 2023 in Review

Bedell Frazier Investment Counselling sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 500 shares — an estimated $250K sold.

Bedell Frazier Investment Counselling first reported a position in IDXX in Q1 2021 and held it in 7 quarters. The position peaked at $329K in Q4 2021. 1,069 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Bedell Frazier Investment Counselling reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Bedell Frazier Investment Counselling sold 500 Idexx Laboratories shares in Q2 2023, an estimated $250K.
Bedell Frazier Investment Counselling first reported a position in Idexx Laboratories in Q1 2021 and held it in 7 quarters.
Bedell Frazier Investment Counselling's Idexx Laboratories position peaked at $329K in Q4 2021.
1,069 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Bedell Frazier Investment Counselling's 13F filing for Q2 2023, filed 14 Aug 2023.